**Question:** Which of the following drugs have narrow therapeutic index

**Core Concept:** A narrow therapeutic index (TTI) refers to a drug with a small range of effective doses or concentrations, where even slight variations can lead to severe adverse effects or therapeutic failure. This concept is essential to understand when evaluating drug choice and dosage in clinical practice.

**Why the Correct Answer is Right:** The correct answer, **D. Morphine**, has a narrow therapeutic index due to its potent analgesic effect and potential for respiratory depression, cardiovascular side effects, and addiction. In clinical practice, morphine dosage must be carefully titrated to achieve the desired pain relief without causing life-threatening complications.

**Why Each Wrong Option is Incorrect:**

A. **Digoxin:** Although digoxin has a narrow therapeutic index, the reason for this is its role in cardiac glycoside therapy for heart failure and atrial fibrillation. It is not primarily due to potential side effects like digitalis toxicity.

B. **Ibuprofen:** Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), has a moderate therapeutic index due to gastrointestinal side effects (e.g., ulcers, bleeding), renal toxicity, and cardiovascular risks. The therapeutic index is not inherently narrow in this case.

C. **Aspirin:** Aspirin, another NSAID, also has a moderate therapeutic index due to gastrointestinal and renal side effects, as well as potential bleeding complications. However, it differs from ibuprofen as it irreversibly inhibits platelet cyclooxygenase enzymes, leading to antiplatelet effects and reduced risk of cardiovascular events, making aspirin a valuable tool in preventing heart attacks and strokes.

**Clinical Pearl:** Understanding the therapeutic index is crucial for selecting appropriate drug treatment options, monitoring dosages, and preventing adverse events. When faced with patients on narrow therapeutic index drugs, close monitoring and frequent drug level checks may be necessary to ensure optimal therapeutic outcomes and minimize toxicity.